Under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG, which is one of the world’s leading medical technology companies, the Medical Technology activities of ZEISS are bundled. Carl Zeiss AG holds ca. 65 percent interest.
Carl Zeiss Meditec AG, Jena, Germany, is the parent company of the Carl Zeiss Meditec group, which comprises additional subsidairies such as Carl Zeiss Meditec Inc. and Carl Zeiss Meditec Iberia S.A..
The Carl Zeiss Meditec AG has set itself the task to develop innovative products to improve the diagnosis and treatment of diseases. The solutions the Company develops aim to simplify clinical workflows and allow physicians to focus all their attention on their work and their patients. After all, at the end we want the patient to leave the clinic with the best possible outcome and a high level of satisfaction.
We supply and provide
- innovative technologies and application-oriented solutions designed to help doctors improve their patients' quality of life
- complete packages of solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables
- innovative visualization solutions in the field of microsurgery
- promising, future-oriented technologies such as intraoperative radiotherapy.
Therefor we are guided by our Mission to uniquely enable healthcare professionals worldwide to improve the lives of their patients in ophthalmology, microsurgery and other medical growth sectors and advance the standards of care with our proven medical technology and application competence. Together with our colleagues at sites all over the world, we work to achieve this goal on a daily basis.